Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Brain neural circuits involved in attention regulation" refers to interconnected regions and neurotransmitter systems—primarily in the cortex (notably prefrontal and parietal areas) and subcortical structures (such as the locus coeruleus, basal forebrain, thalamus, and superior colliculus)—which underlie attentional focus, selection, and impulse control[1][2][3][5][7]. These networks are modulated by key neuromodulators (norepinephrine, acetylcholine, dopamine), involving diverse populations of excitatory and inhibitory neurons whose activity patterns shape attentional performance and flexibility[2][3][5][6]. Dysfunction or altered molecular heterogeneity within these circuits is implicated in disorders such as ADHD, autism spectrum disorder, and schizophrenia[4]. Since this is not a single molecular entity, it is not considered a canonical therapeutic target in the conventional sense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Brain neural circuits involved in attention regulation.